KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) EBT Margin (2016 - 2026)

Abbott Laboratories' EBT Margin history spans 18 years, with the latest figure at 12.98% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 419.0% to 12.98% in Q1 2026 year-over-year; TTM through Mar 2026 was 18.03%, a 66.0% increase, with the full-year FY2025 number at 19.1%, up 238.0% from a year prior.
  • EBT Margin hit 12.98% in Q1 2026 for Abbott Laboratories, down from 20.58% in the prior quarter.
  • Over the last five years, EBT Margin for ABT hit a ceiling of 24.18% in Q1 2022 and a floor of 12.98% in Q1 2026.
  • Historically, EBT Margin has averaged 17.49% across 5 years, with a median of 17.17% in 2025.
  • Biggest five-year swings in EBT Margin: skyrocketed 771bps in 2022 and later plummeted -815bps in 2023.
  • Tracing ABT's EBT Margin over 5 years: stood at 13.08% in 2022, then skyrocketed by 34bps to 17.53% in 2023, then grew by 6bps to 18.5% in 2024, then rose by 11bps to 20.58% in 2025, then plummeted by -37bps to 12.98% in 2026.
  • Business Quant data shows EBT Margin for ABT at 12.98% in Q1 2026, 20.58% in Q4 2025, and 19.17% in Q3 2025.